SOURCE: HealthSonix, Inc.

October 04, 2007 08:00 ET

HealthSonix Launches Major Media Campaign for ZingiberRx Topical Pain Reliever

IRVINE, CA--(Marketwire - October 4, 2007) - HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced that it has launched a major Media campaign in North America for ZingiberRx through Synergy Management Group. This comprehensive media blitz has been aimed at a cross-section of media, including wellness, health, general interest, sports, travel, seniors medical, and other special interest magazines, as well as internet vehicles, general newspapers and magazines, TV and community newspapers.

"The word is out," said Jay Silverberg, of Synergy Management Group. "The reaction from the media marketplace is exceptional. It seems that ZingiberRX is generating interest and excitement. Positioned between prescription medication and all those traditional, staid, over-the-counter products, ZingiberRX is an exciting alternative that is being recognized by the media, and wellness / health care providers."

"We have already received numerous call backs requesting more information and samples resulting from this effort, which only started last week," said Dieter D. Doederlein, Vice President Corporate Development for HealthSonix. "It seems that a common thread is the efficacy and affordability of our product, particularly for the 47 million American citizens who cannot afford medical insurance," he added.

"We feel that HealthSonix has medical products that will have a worldwide impact, and the initial response to our program is confirmation," said Jay Silverberg, President & CEO, Synergy Management Group Ltd. "In our experience, products that will have an impact usually capture the media's attention at an early stage," said Mr. Silverberg.

Customers can order ZingiberRx online at, or by calling the Company toll-free line at 1-877-622-2121. Affordably priced at $24.95 per tube, ZingiberRx comes in 80 gram tubes, which will typically provide a month of pain relief.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core products are based on proprietary, patent-pending medical technologies that use sound pressure waves to stimulate soft tissue, muscles and sensory and mechanoreceptors in the human body to relieve pain. All treatments and products are safe, non-invasive, and have no known side effects.

More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information